EATON VANCE MANAGEMENT - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 252 filers reported holding CONMED CORP in Q2 2021. The put-call ratio across all filers is 8.16 and the average weighting 0.1%.

Quarter-by-quarter ownership
EATON VANCE MANAGEMENT ownership history of CONMED CORP
ValueSharesWeighting
Q3 2022$270,000
-15.9%
3,369
+0.6%
0.00%
Q2 2022$321,000
-51.9%
3,350
-25.5%
0.00%
-100.0%
Q1 2022$668,000
+3.9%
4,499
-0.8%
0.00%0.0%
Q4 2021$643,000
+52.0%
4,535
+4.6%
0.00%0.0%
Q3 2021$423,000
-28.4%
4,335
+0.7%
0.00%0.0%
Q2 2021$591,000
+30.8%
4,303
+24.4%
0.00%0.0%
Q1 2021$452,000
-39.9%
3,459
-48.5%
0.00%0.0%
Q4 2020$752,000
+184.8%
6,722
+100.0%
0.00%
Q3 2020$264,000
+10.0%
3,361
+0.7%
0.00%
Q2 2020$240,0003,3380.00%
Other shareholders
CONMED CORP shareholders Q2 2021
NameSharesValueWeighting ↓
Hood River Capital Management LLC 448,126$38,346,0001.80%
HealthCor Management, L.P. 455,190$38,951,0001.51%
Champlain Investment Partners, LLC 1,452,360$124,278,0001.04%
J. Goldman & Co LP 162,771$13,928,0000.96%
Granahan Investment Management 189,925$16,252,0000.80%
PURA VIDA INVESTMENTS, LLC 50,000$4,279,0000.65%
OAK RIDGE INVESTMENTS LLC 102,797$8,797,0000.61%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 78,722$6,736,0000.54%
MOODY ALDRICH PARTNERS LLC 23,834$2,039,0000.52%
361 CAPITAL LLC 30,901$2,644,0000.47%
View complete list of CONMED CORP shareholders